Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in BioNTech

BioNTech Begins Trials Of mRNA-based Malaria Vaccine

Scientists around the world have been working for decades to develop a vaccine to prevent malaria, which infects millions of people every year and leads to hundreds of thousands of deaths - most of them babies and young children in the poorest parts of Africa

Read More

Germany Sends First Batch Of BioNTech Vaccines To Covid Hit China

The shipment comes after China agreed to allow German nationals in China to get the shot following a deal during Chancellor Olaf Scholz's visit in Beijing last month, with the German leader pressing for Beijing to allow the shot to be made freely available to Chinese citizens as well

Read More

Pfizer, BioNTech Omicron Booster Delivers Strong Response

Omicron-tailored shots made by Pfizer and rival Moderna Inc have already been given the green light in the United States for adults as well as for children as young as five years

Read More

Pfizer, BioNTech Seek FDA Approval For New Covid Boosters For Kids

The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11

Read More

Moderna Sues Pfizer & BioNTech For Patent Infringement Over mRNA Vaccine

Moderna believes that Pfizer and BioNTech's COVID-19 vaccine Comirnaty infringes patents Moderna filed between 2010 and 2016 covering Moderna's foundational mRNA technology. This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax

Read More

Pfizer Says COVID-19 Vaccine Works In Kids Ages 5 To 11

But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.

Read More

Serum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU

The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.

Read More

FDA Advisory Panel To Review Johnson & Johnson COVID-19 Vaccine With Thumbs Up Expected

J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

Read More

Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

Pfizer, BioNTech begin testing of third dose against new COVID-19 variants

Read More

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand

BioNTech to produce 2 billion doses of COVID-19 vaccine in 2021 amid surge in global demand

Read More

J&J Vaccine Adds To COVID-19 Armoury, Includes South African Variant

J&J shares were down 4% at $162.7 at 1700 GMT, with some Wall Street analysts saying its vaccine's effectiveness was below those of rivals. Moderna's stock gained 8% to $172.80.

Read More

New Zealand's COVID-19 vaccine slated for possible approval next week

New Zealand's COVID-19 vaccine slated for possible approval next week

Read More

Pfizer, BioNTech to scale-up vaccine production amid reports on shortage in deliveries

Pfizer, BioNTech to scale-up vaccine production amid reports on shortage in deliveries

Read More

Biden receives second dose of Pfizer-BioNTech coronavirus vaccine

Biden receives second dose of Pfizer-BioNTech coronavirus vaccine

Read More

EU secures deal to double Pfizer-BioNTech vaccine supply

EU secures deal to double Pfizer-BioNTech vaccine supply

Read More